Other languages Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Market Closed - Japan Exchange Other stock markets 11:30:00 26/04/2024 am IST			5-day change	1st Jan Change
6,370 ^JPY	+1.56%		+2.97%	+20.44%

09/04	H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	MT
29/03	Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	09/04
Bourses asiatiques: Tokyo mi-figue, mi-raisin, Hong Kong confiante	02/04
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia	27/03
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	16/02
Otsuka Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending December 31, 2024	16/02
Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending December 31, 2024	16/02
MÄRKTE ASIEN/Schwach - Zinssenkungshoffnungen schwinden	14/02
MÄRKTE ASIEN/Leichter nach US-Dämpfer für Zinssenkungshoffnungen	14/02
Otsuka Holdings Co., Ltd. Announces Year-End Dividend for the Year Ended December 31, 2023, Payable on March 29 , 2024; Provides Second Quarter-End Dividend Guidance for the Fiscal Year 2024	14/02
Otsuka Holdings Lowers 2023 Profit Outlook	13/02
Japan's Nikkei cruises to 34-year peak, briefly breaching 38,000 range	13/02
Japan's Nikkei soars to 34-year high on chip shares, earnings	13/02
Otsuka's drug for Alzheimer's disease agitation fails in late stage study	13/02
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023	13/02
Ionis Pharmaceuticals Says Potential Angioedema Treatment Met Primary Endpoint of Phase 3 Study	22/01
Marchés mondiaux: l'Europe dans le vert avant l'inflation américaine	11/01
Tokyo: le Nikkei au-delà des 35.000 points, une première depuis 34 ans	11/01
Tokyo: le Nikkei finit au-dessus des 35.000 points, une première depuis 34 ans	11/01
Ionis Pharmaceuticals Signs Europe Licensing Deal With Otsuka for Donidalorsen in Hereditary Angioedema	19/12
Otsuka's Unit Remains as MicroPort Scientific's Thai Distributor Until 2026	18/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Other languages

Filters